Bernard Gilly is the founder of GenSight Biologics. GenSight Biologics has raised $264M in total funding. Based in Paris, France.
Bernard Gilly is a French biotech entrepreneur and co-founder of GenSight Biologics, a clinical-stage company focused on therapies for mitochondrial and neurodegenerative diseases of the eye. He has also held leadership roles at BrainEver and Ibionext.
Full founder directory · Investor directory · Company funding database · Fundraising library